Cura Therapeutics

Private

Montreal, QuebecHealthcare & Life Scienceshttps://www.curatherapeutics.com/

Last Round

Accelerator

Nov 25, 2025

Total Funding Raised

$125,000

Company Overview

Cura Therapeutics is a biotechnology company developing multimodal immunotherapies to treat metastatic cancers, pathogen infections, and age-associated diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

immunotherapymultimodal immunotherapyimmuno-oncologybiologicsfusion proteinspharma partnershipsprotein engineeringcancer therapeuticsmetastatic cancerAI drug discoverypreclinical biotechdrug discovery platformrecombinant proteinssolid tumor therapytumor microenvironment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cura Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Cura Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cura Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Nov 25, 2025
Accelerator	Mar 6, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Claudia Penafuerte

Cofounder and CEO

Founding Team

Cura Therapeutics Investors

Notable investors and investment history

Cura Therapeutics investors
Investor	Rounds
Ontario Bioscience Innovation Organization	Accelerator
Capital BioVentures	Accelerator
FACIT	Accelerator, Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 2, 2025
Monthly visitors grew 116% MoM.
Dec 16, 2024
Monthly visitors increased 122% MoM, reaching 175.

View all signals

Cura Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cura Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cura Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal, Quebec

Employee Range3

Year Founded2017

Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.